JPH11178A5 - - Google Patents

Info

Publication number
JPH11178A5
JPH11178A5 JP1998024524A JP2452498A JPH11178A5 JP H11178 A5 JPH11178 A5 JP H11178A5 JP 1998024524 A JP1998024524 A JP 1998024524A JP 2452498 A JP2452498 A JP 2452498A JP H11178 A5 JPH11178 A5 JP H11178A5
Authority
JP
Japan
Prior art keywords
sequence
promoter
nucleic acid
acid construct
human endoglin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998024524A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11178A (ja
Filing date
Publication date
Priority claimed from DE19704301A external-priority patent/DE19704301C1/de
Application filed filed Critical
Publication of JPH11178A publication Critical patent/JPH11178A/ja
Publication of JPH11178A5 publication Critical patent/JPH11178A5/ja
Withdrawn legal-status Critical Current

Links

JP10024524A 1997-02-06 1998-02-05 ヒトエンドグリン遺伝子プロモーターおよびその使用 Withdrawn JPH11178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19704301.1 1997-02-06
DE19704301A DE19704301C1 (de) 1997-02-06 1997-02-06 Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie

Publications (2)

Publication Number Publication Date
JPH11178A JPH11178A (ja) 1999-01-06
JPH11178A5 true JPH11178A5 (cg-RX-API-DMAC10.html) 2005-08-04

Family

ID=7819364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10024524A Withdrawn JPH11178A (ja) 1997-02-06 1998-02-05 ヒトエンドグリン遺伝子プロモーターおよびその使用

Country Status (15)

Country Link
US (1) US6103527A (cg-RX-API-DMAC10.html)
EP (1) EP0857781A3 (cg-RX-API-DMAC10.html)
JP (1) JPH11178A (cg-RX-API-DMAC10.html)
KR (1) KR19980071084A (cg-RX-API-DMAC10.html)
CN (1) CN1196784C (cg-RX-API-DMAC10.html)
AR (1) AR011110A1 (cg-RX-API-DMAC10.html)
AU (1) AU736724B2 (cg-RX-API-DMAC10.html)
BR (1) BR9800563A (cg-RX-API-DMAC10.html)
CA (1) CA2222981A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ289227B6 (cg-RX-API-DMAC10.html)
DE (1) DE19704301C1 (cg-RX-API-DMAC10.html)
HU (1) HUP9800247A3 (cg-RX-API-DMAC10.html)
PL (1) PL324688A1 (cg-RX-API-DMAC10.html)
RU (1) RU2230115C2 (cg-RX-API-DMAC10.html)
TR (1) TR199800168A2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19704301C1 (de) * 1997-02-06 1998-03-26 Hoechst Ag Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie
CZ121599A3 (cs) 1998-04-09 1999-10-13 Aventis Pharma Deutschland Gmbh Jednořetězcová molekula vázající několik antigenů, způsob její přípravy a léčivo obsahující tuto molekulu
KR100636578B1 (ko) 1999-04-02 2006-10-19 히사미쓰 세이야꾸 가부시키가이샤 치료용 유전자 발현 염기서열 및 유전자 치료용 약제
RU2295281C2 (ru) * 2005-04-20 2007-03-20 Федеральное государственное учреждение Научно-исследовательский институт детских инфекций, г.Санкт-Петербург Способ оценки тяжести инфекционного поражения цнс у детей
RU2297848C2 (ru) * 2005-05-11 2007-04-27 Александр Веньяминович Иткес Генно-инженерная конструкция vegf-ибмед (vegf-ibmed)
US20090136465A1 (en) 2007-09-28 2009-05-28 Intrexon Corporation Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
WO2010005850A1 (en) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Methods and compositions for modulating angiogenesis
WO2014123749A1 (en) 2013-01-30 2014-08-14 Board Of Regents Of The University Of Nebraska Compositions and methods for treating complications associated with diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466596A (en) * 1992-08-25 1995-11-14 Mount Sinai Hospital Corporation Tissue specific transcriptional regulatory element
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
DE19704301C1 (de) * 1997-02-06 1998-03-26 Hoechst Ag Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie

Similar Documents

Publication Publication Date Title
JP2002519061A5 (cg-RX-API-DMAC10.html)
JP2003525623A5 (cg-RX-API-DMAC10.html)
CA2154023A1 (en) Recombinant infectious non-segmented negative strand rna virus
JP2001524320A5 (cg-RX-API-DMAC10.html)
WO1999038972A9 (en) Human genes and gene expression products ii
JP2002535956A5 (cg-RX-API-DMAC10.html)
JP2003520017A5 (cg-RX-API-DMAC10.html)
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
JPH11178A5 (cg-RX-API-DMAC10.html)
EP1209228A3 (en) Environmental stress responsive promoter
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
NZ508439A (en) Novel endometriosis-associated gene
WO2000043490A3 (en) Rhamnosyl-transferase gene and uses thereof
WO1999028439A3 (fr) Erythrovirus et ses applications
CA2340934A1 (en) Novel collectin
EP1849868A3 (en) Plant defensins
IT1299184B1 (it) Sequenze nucleotidiche del gene lrpkm1 di melo, sequenze amminoacidiche e loro usi.
ATE394494T1 (de) Isolierte polynucleotide mit einem verminderten anteil an 5'cpg3' epigenetischen kontrollmotiven, und verwendungen davon
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
WO2000018916A3 (en) Human genes and gene expression products
JPH10210974A5 (cg-RX-API-DMAC10.html)
WO2003031459A3 (de) Modulation der expression stat-1-abhängiger gene
WO2003033692A3 (de) Verwendung des adenoviralen e2-late-promotors
JP2003284553A5 (cg-RX-API-DMAC10.html)